curve lines

Cyclone® 70

Choose with confidence.

  • PET Imaging
  • 82Sr
  • 68Ge
  • 123I
  • Multi targets, high capacity

    Thanks to its multi-targets layout, this machine fits perfectly with routine production needs using high-energy proton.

  • Choose with confidence

    The Cyclone® 70 family offers wide flexibility both in accelerated current and energy giving you a large range of options for production.

  • Cyclone 70
  • Cyclone 70
  • image
  • Energy

    From 30 to 70 MeV

  • Cyclotron dimensions

    4 x 3.8 m

  • Target

    Multipurpose solid target & gas targets

  • Vault dimensions

    12 x 10 m

  • Exit ports

    2 simultaneous extracted beams

  • Production power

    750 µA

  • Beam lines

    Up to 6 long beam lines

  • Highly efficient and reliable

    Optimized vacuum to ensure efficient acceleration and low running costs, while maintaining maximum uptime thanks to the IBA design of RF system and modular power supplies.

  • Dual beam extraction

    Energy range from 30 to 70 MeV gives you the flexibility to produce a wide range of radioisotopes, including 82Sr, 68Ge and 123I.

  • Proven expertise

    IBA is the only company able to provide a high level of expertise and success with the installation and operation of six 70 MeV cyclotrons.

  • Ready when you are

    IBA promises that your cyclotron is available when you are ready with your building.

curve lines
  • Interested to learn more about the Cyclone® 70?

    Download product information

    Find out everything you need to know about the Cyclone® 70.

You don’t only have to take our word for it. Here is what others say about the Cyclone® 70.

Quote illustration image
Le Roux Strydom
Dr. Le Roux Strydom
Head of Accelerator Operations & Technical Support
iThemba LABS, South Africa

We are extremely pleased with the outcome of this project.

“We are extremely pleased with the outcome of this project. The project management was exceptional and having direct access to IBA’s experts added significant value to our experience. Our confidence in IBA’s high energy systems has been solidified by their demonstrated expertise, particularly with the 70 MeV cyclotron. We eagerly anticipate our continued collaboration with IBA, a proven leader in cyclotron technology.”

IBA high-energy cyclotrons installed across the world

    High-energy cyclotron
curve lines
Quote illustration image
Jean-Michel Geets
Jean-Michel Geets
Domain Principal Expert
IBA RadioPharma Solutions

The IBA Cyclone® 70 is the benchmark for high-capacity 82Sr and 68Ge production.

“With its proven reliability, dual-beam extraction, and flexibility for multiple targets, it delivers unmatched efficiency for industrial and medical applications. Its compact design and low operating costs make it the ideal choice for facilities seeking long-term performance and productivity.”

  • iba press release
    • 23/01/2024
    iThemba LABS ready to start production of Strontium-82 and Germanium-68 using IBA Cyclone® 70

    Louvain-la-Neuve, Belgium, January 23, 2024 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of radiopharmaceutical production solutions, is pleased to announce that the Cyclone® 70 system installed at the iThemba Laboratory for Accelerator Based Sciences (iThemba LABS) in Cape Town, one of the research facilities of the National Research Foundation of South Africa, has been fully commissioned enabling iThemba LABS to start transferring the production of radioisotopes from their existing accelerator to the new Cyclone® 70 system.
     

    Acceptance testing was completed in December 2023, with the cyclotron reaching full beam power (750µA) at full energy. This 70 MeV cyclotron will be dedicated to the production of next-generation medical isotopes used mainly in the diagnosis of critical illnesses. The machine will be used primarily for the manufacture of Strontium-82 for use in the diagnosis of cardiovascular disease, as well as for production of Germanium-68 for use in positron emission tomography (PET) imaging.
     

    Dr Le Roux Strydom, Head of Accelerator Operations & Technical Support at iThemba LABS, said: “We are extremely pleased with the outcome of this project. The project management was exceptional and having direct access to IBA’s experts added significant value to our experience. Our confidence in IBA’s high energy systems has been solidified by their demonstrated expertise, particularly with the 70 MeV cyclotron. We eagerly anticipate our continued collaboration with IBA, a proven leader in cyclotron technology.”
     

    Bruno Scutnaire, President at IBA RadioPharma Solutions, added: “We are proud to announce yet another demonstration of our expertise in 70 MeV machines with this project, with installation successfully completed and iThemba LABS ready to start the production of Strontium-82 and other radioisotopes. This latest accomplishment strengthens our leading position in cyclotron technology and attests to our commitment to delivering cutting-edge solutions to meet our clients’ needs. To date, six Cyclone® 70 MeV machines and over 35 cyclotrons of 30 MeV have been installed worldwide. We see a growing interest for these high energy machines, driven by an increasing number of clinical trials exploring new diagnostic or radiotherapeutic molecules.”

    More details
  • Cyclone 70 Zevacor
    • 01/01/2022
    IBA Cyclone® 70 at Zevacor Molecular fully operational

    New IBA Cyclone® 70 at Zevacor Molecular fully operational ahead of schedule for production of radioisotopes.

    More details
  • Rigging IBS
    • 25/01/2022
    The impressive rigging of the IBA Cyclone® 70 cyclotron at the Institute of Basic Sciences (IBS)

    When a 140 tons cyclotron has to be placed into its vault, it is always impressive ! It requires precision expertise and a close attention to every details. The IBA Cyclone® 70 MeV Cyclotron was successfully rigged by part before being reassembled in the vault of the Institute of Basic Science in Korea. It is now time to celebrate and congratulate all the people involved in this important project's milestone.

    The Institute of Basic Science (IBS) is constructing equipment and facilities for the Rare isotope Accelerator complex for ON-line experiments (RAON). RAON is a large basic science research facility built around a heavy-ion accelerator. When completed, it will be a key pillar of the International Science and Business Belt (ISBB). This will be an optimal facility to produce and study new rare isotopes, so the global scientific community is closely following its progress.
     

    The Cyclone® 70 will be one of the drivers of the RAON facility. Scientists have discovered approximately 3,000 isotopes to date, but they believe an additional 7,000 isotopes have yet to be discovered, presenting unlimited potential for rare isotope science. When the operation of RAON begins, new research opportunities will open up in various areas, such as research into the origin of elements, discovery of new rare isotopes and the study of their structure, and applied research in material and biomedical sciences.
     

    The Institute of Basic Science (IBS) is constructing equipment and facilities for the Rare isotope Accelerator complex for ON-line experiments (RAON). RAON is a large basic science research facility built around a heavy-ion accelerator. When completed, it will be a key pillar of the International Science and Business Belt (ISBB). This will be an optimal facility to produce and study new rare isotopes, so the global scientific community is closely following its progress.
     

    The Cyclone® 70 will be one of the drivers of the RAON facility. Scientists have discovered approximately 3,000 isotopes to date, but they believe an additional 7,000 isotopes have yet to be discovered, presenting unlimited potential for rare isotope science. When the operation of RAON begins, new research opportunities will open up in various areas, such as research into the origin of elements, discovery of new rare isotopes and the study of their structure, and applied research in material and biomedical sciences.

    More details